Sandrine Parrot

Dr. Sandrine Parrot

Lyon Neuroscience Research Center, Inserm U1028, CNRS UMR5292, University of Lyon, France
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2005 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
ILI. Léna
I. Léna
SPSandrine Parrot
Sandrine Parrot
ODO. Deschaux
O. Deschaux
SMS. Muffat‐Joly
S. Muffat‐Joly
VSV. Sauvinet
V. Sauvinet
CGC. Gottesmann
C. Gottesmann

2 December 2014 in Molecular Psychiatry
Verified
Journal Article
Open access
CLC Laurent
C Laurent
SBS Burnouf
S Burnouf
BFBarbara Ferry
Barbara Ferry
VBV L Batalha
V L Batalha
JCJ E Coelho
J E Coelho
DBDavid Blum
David Blum
Consumption of caffeine, a non-selective adenosine A2A receptor (A2AR) antagonist, reduces the risk of developing Alzheimer’s disease (AD) in humans and mitigates both amyloid and Tau burden in transgenic mouse models. However, the impact of selective A2AR blockade on the progressive development of AD-related lesions and associated memory impairments has not been investigated. In the present study, we removed the gene encoding A2AR from THY-Tau22 mice and analysed the subsequent effects on both pathological (Tau phosphorylation and aggregation, neuro-inflammation) and functional impairments (spatial learning and memory, hippocampal plasticity, neurotransmitter profile). We found that deleting A2ARs protect from Tau pathology-induced deficits in terms of spatial memory and hippocampal long-term depression. These effects were concomitant with a normalization of the hippocampal glutamate/gamma-amino butyric acid ratio, together with a global reduction in neuro-inflammatory markers and a decrease in Tau hyperphosphorylation. Additionally, oral therapy using a specific A2AR antagonist (MSX-3) significantly improved memory and reduced Tau hyperphosphorylation in THY-Tau22 mice. By showing that A2AR genetic or pharmacological blockade improves the pathological phenotype in a Tau transgenic mouse model, the present data highlight A2A receptors as important molecular targets to consider against AD and Tauopathies.

26 April 2006 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JMJustine Masson
Justine Masson
MDMichèle Darmon
Michèle Darmon
ACAgnès Conjard
Agnès Conjard
NCNao Chuhma
Nao Chuhma
NRNicole Ropert
Nicole Ropert
SRStephen Rayport
Stephen Rayport
Neurotransmitter glutamate has been thought to derive mainly from glutamine via the action of glutaminase type 1 (GLS1). To address the importance of this pathway in glutamatergic transmission, we knocked out GLS1 in mice. The insertion of a STOP cassette by homologous recombination produced a null allele that blocked transcription, encoded no immunoreactive protein, and abolished GLS1 enzymatic activity. Null mutants were slightly smaller, were deficient in goal-directed behavior, hypoventilated, and died in the first postnatal day. No gross or microscopic defects were detected in peripheral organs or in the CNS. In cultured neurons from the null mutants, miniature EPSC amplitude and duration were normal; however, the amplitude of evoked EPSCs decayed more rapidly with sustained 10 Hz stimulation, consistent with an observed reduction in depolarization-evoked glutamate release. Because of this activity-dependent impairment in glutamatergic transmission, we surmised that respiratory networks, which require temporal summation of synaptic input, would be particularly affected. We found that the amplitude of inspirations was decreasedin vivo, chemosensitivity to CO2was severely altered, and the frequency of pacemaker activity recorded in the respiratory generator in the pre-Bötzinger complex, a glutamatergic brainstem network that can be isolatedin vitro, was increased. Our results show that although alternate pathways to GLS1 glutamate synthesis support baseline glutamatergic transmission, the GLS1 pathway is essential for maintaining the function of active synapses, and thus the mutation is associated with impaired respiratory function, abnormal goal-directed behavior, and neonatal demise.

1 March 2014 in Journal of Chromatography B
Verified
Journal Article
Closed access
BFBarbara Ferry
Barbara Ferry
EGElena-Patricia Gifu
Elena-Patricia Gifu
ISIoana Sandu
Ioana Sandu
LDLuc Denoroy
Luc Denoroy
SPSandrine Parrot
Sandrine Parrot

27 March 2003 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
SPSandrine Parrot
Sandrine Parrot
PDPascal Degraeve
Pascal Degraeve
CCCéline Curia
Céline Curia
AMAdèle Martial‐Gros
Adèle Martial‐Gros

1 December 2011 in Journal of Chromatography B
Verified
Journal Article
Closed access
SPSandrine Parrot
Sandrine Parrot
PNPierre-Charles Neuzeret
Pierre-Charles Neuzeret
LDLuc Denoroy
Luc Denoroy